196 related articles for article (PubMed ID: 9502489)
1. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB
Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489
[No Abstract] [Full Text] [Related]
2. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
4. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
[TBL] [Abstract][Full Text] [Related]
5. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
Muluneh B; Dean A; Armistead P; Khan T
J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
[TBL] [Abstract][Full Text] [Related]
6. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
7. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
9. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
Chen Y; Scieux C; Garrait V; Socié G; Rocha V; Molina JM; Thouvenot D; Morfin F; Hocqueloux L; Garderet L; Espérou H; Sélimi F; Devergie A; Leleu G; Aymard M; Morinet F; Gluckman E; Ribaud P
Clin Infect Dis; 2000 Oct; 31(4):927-35. PubMed ID: 11049772
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
Lalezari J; Schacker T; Feinberg J; Gathe J; Lee S; Cheung T; Kramer F; Kessler H; Corey L; Drew WL; Boggs J; McGuire B; Jaffe HS; Safrin S
J Infect Dis; 1997 Oct; 176(4):892-8. PubMed ID: 9333146
[TBL] [Abstract][Full Text] [Related]
11. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP
Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus resistance to antiviral drugs.
Morfin F; Thouvenot D
J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
[TBL] [Abstract][Full Text] [Related]
13. New modified 2-aminobenzimidazole nucleosides: Synthesis and evaluation of their activity against herpes simplex virus type 1.
Kharitonova MI; Denisova AO; Andronova VL; Kayushin AL; Konstantinova ID; Kotovskaya SK; Galegov GA; Charushin VN; Miroshnikov AI
Bioorg Med Chem Lett; 2017 Jun; 27(11):2484-2487. PubMed ID: 28408228
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
Maggs DJ; Clarke HE
Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of cidofovir in an HIV infected patient with an acyclovir and foscarnet resistant herpes simplex virus infection].
Saint-Léger E; Fillet AM; Malvy D; Rabanel B; Caumes E
Ann Dermatol Venereol; 2001; 128(6-7):747-9. PubMed ID: 11460038
[TBL] [Abstract][Full Text] [Related]
16. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
Lateef F; Don PC; Kaufmann M; White SM; Weinberg JM
Arch Dermatol; 1998 Sep; 134(9):1169-70. PubMed ID: 9762047
[No Abstract] [Full Text] [Related]
18. [In vitro acyclovir and cidofovir susceptibilities of human herpesvirus type 1 clinical isolates].
Cieśluk B; Dzieciatkowski T; Majewska A; Łuczak M
Med Dosw Mikrobiol; 2008; 60(2):163-8. PubMed ID: 18819452
[TBL] [Abstract][Full Text] [Related]
19. Cidofovir use in acyclovir-resistant herpes infection.
Martinez CM; Luks-Golger DB
Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391
[TBL] [Abstract][Full Text] [Related]
20. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA
Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]